250 related articles for article (PubMed ID: 9327130)
1. Design and synthesis of [111In]DTPA-folate for use as a tumor-targeted radiopharmaceutical.
Wang S; Luo J; Lantrip DA; Waters DJ; Mathias CJ; Green MA; Fuchs PL; Low PS
Bioconjug Chem; 1997; 8(5):673-9. PubMed ID: 9327130
[TBL] [Abstract][Full Text] [Related]
2. Indium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceutical.
Mathias CJ; Wang S; Waters DJ; Turek JJ; Low PS; Green MA
J Nucl Med; 1998 Sep; 39(9):1579-85. PubMed ID: 9744347
[TBL] [Abstract][Full Text] [Related]
3. Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate.
Mathias CJ; Wang S; Lee RJ; Waters DJ; Low PS; Green MA
J Nucl Med; 1996 Jun; 37(6):1003-8. PubMed ID: 8683292
[TBL] [Abstract][Full Text] [Related]
4. Pemetrexed improves tumor selectivity of 111In-DTPA-folate in mice with folate receptor-positive ovarian cancer.
Müller C; Schibli R; Krenning EP; de Jong M
J Nucl Med; 2008 Apr; 49(4):623-9. PubMed ID: 18344429
[TBL] [Abstract][Full Text] [Related]
5. Targeting the tumor-associated folate receptor with an 111In-DTPA conjugate of pteroic acid.
Ke CY; Mathias CJ; Green MA
J Am Chem Soc; 2005 May; 127(20):7421-6. PubMed ID: 15898791
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine--folate, a potential radiopharmaceutical for tumor imaging.
Wang S; Lee RJ; Mathias CJ; Green MA; Low PS
Bioconjug Chem; 1996; 7(1):56-62. PubMed ID: 8741991
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of 99mTc(CO)(3)-DTPA-folate as a folate-receptor-targeted radiopharmaceutical.
Trump DP; Mathias CJ; Yang Z; Low PS; Marmion M; Green MA
Nucl Med Biol; 2002 Jul; 29(5):569-73. PubMed ID: 12088727
[TBL] [Abstract][Full Text] [Related]
8. Imaging tumor folate receptors using 111In-DTPA-methotrexate.
Ilgan S; Yang DJ; Higuchi T; Zareneyrizi F; Kim EE; Podoloff DA
Cancer Biother Radiopharm; 1998 Jun; 13(3):177-84. PubMed ID: 10850353
[TBL] [Abstract][Full Text] [Related]
9. A kit formulation for preparation of [(111)In]In-DTPA-folate, a folate-receptor-targeted radiopharmaceutical.
Mathias CJ; Green MA
Nucl Med Biol; 1998 Aug; 25(6):585-7. PubMed ID: 9751427
[TBL] [Abstract][Full Text] [Related]
10. Folate-PEG-CKK(2)-DTPA, A Potential Carrier for Lymph-Metastasized Tumor Targeting.
Gu B; Xie C; Zhu J; He W; Lu W
Pharm Res; 2010 May; 27(5):933-42. PubMed ID: 20221899
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results.
Siegel BA; Dehdashti F; Mutch DG; Podoloff DA; Wendt R; Sutton GP; Burt RW; Ellis PR; Mathias CJ; Green MA; Gershenson DM
J Nucl Med; 2003 May; 44(5):700-7. PubMed ID: 12732670
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of diethylenetriamine pentaacetic acid-polyethylene glycol-folate: a new folate-derived, (99m)Tc-based radiopharmaceutical.
Liu M; Xu W; Xu LJ; Zhong GR; Chen SL; Lu WY
Bioconjug Chem; 2005; 16(5):1126-32. PubMed ID: 16173789
[TBL] [Abstract][Full Text] [Related]
13. Receptor-mediated targeting of 67Ga-deferoxamine-folate to folate-receptor-positive human KB tumor xenografts.
Mathias CJ; Wang S; Low PS; Waters DJ; Green MA
Nucl Med Biol; 1999 Jan; 26(1):23-5. PubMed ID: 10096497
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluation of (99m)Tc-DO3A-EA-Folate for receptor-mediated targeting of folate positive tumors.
Mishra G; Hazari PP; Kumar N; Mishra AK
J Drug Target; 2011 Nov; 19(9):761-9. PubMed ID: 21425922
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and preclinical evaluation of a folic acid derivative labeled with 18F for PET imaging of folate receptor-positive tumors.
Bettio A; Honer M; Müller C; Brühlmeier M; Müller U; Schibli R; Groehn V; Schubiger AP; Ametamey SM
J Nucl Med; 2006 Jul; 47(7):1153-60. PubMed ID: 16818950
[TBL] [Abstract][Full Text] [Related]
16. 99mTc-Tetraethylenepentamine-Folate--a new 99mTc-based folate derivative for the detection of folate receptor positive tumors: synthesis and biological evaluation.
Panwar P; Shrivastava V; Tandon V; Mishra P; Chuttani K; Sharma RK; Chandra R; Mishra AK
Cancer Biol Ther; 2004 Oct; 3(10):995-1001. PubMed ID: 15467429
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of glutamate-sensitive radiopharmaceuticals: Technetium-99m-glutamic acid and technetium-99m-diethylenetriaminepentaacetic acid-bis(glutamate) conjugate for tumor imaging.
Kakkar D; Tiwari AK; Chuttani K; Kaul A; Singh H; Mishra AK
Cancer Biother Radiopharm; 2010 Dec; 25(6):645-55. PubMed ID: 21204758
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of specific SPECT-radiopharmaceutical for tumor imaging based on methionine: 99mTc-DTPA-bis(methionine).
Hazari PP; Shukla G; Goel V; Chuttani K; Kumar N; Sharma R; Mishra AK
Bioconjug Chem; 2010 Feb; 21(2):229-39. PubMed ID: 20108938
[TBL] [Abstract][Full Text] [Related]
19. Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals.
Mathias CJ; Lewis MR; Reichert DE; Laforest R; Sharp TL; Lewis JS; Yang ZF; Waters DJ; Snyder PW; Low PS; Welch MJ; Green MA
Nucl Med Biol; 2003 Oct; 30(7):725-31. PubMed ID: 14499330
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, biodistribution and imaging properties of indium-111-DTPA-paclitaxel in mice bearing mammary tumors.
Li C; Yu DF; Inoue T; Yang DJ; Tansey W; Liu CW; Milas L; Hunter NR; Kim EE; Wallace S
J Nucl Med; 1997 Jul; 38(7):1042-7. PubMed ID: 9225788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
